Abstract:You have accessJournal of UrologyCME1 May 2022MP53-05 CLINICALLY SIGNIFICANT PROSTATE CANCER DETECTION RATE OF PROSTATE IMAGING REPORTING AND DATA SYSTEM SCORE 4 IN THE PERIPHERAL ZONE Gang Song and Zhoujie Sun Gang SongGang Song More articles by this author and Zhoujie SunZhoujie Sun More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002628.05AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Prostate Imaging Reporting and Data System (PI-RADS) version 2.1 recommends that lesions in the peripheral zone (PZ) are mainly assessed by diffusion-weighted imaging (DWI) and adjusted by dynamic contrast-enhanced (DCE). There are two possible images for PI-RADS 4 lesions in PZ. One is DWI 4, the other is DWI 3 with positive DCE (hereinafter called ‘DWI 3/DCE+’). Our objectives are to compare the clinically significant prostate cancer (csPCa) detection rate between DWI 4 and DWI 3/DCE+ in PZ and to explore the diagnostic performances of targeted biopsy (TB) alone or systematic biopsy (SB) alone for patients with DWI 3/DCE+. METHODS: We retrospectively enrolled 206 patients who underwent multiparametric magnetic resonance imaging and had at least one PI-RADS 4 lesion in the PZ. All patients subsequently underwent combined magnetic resonance imaging/ultrasound fusion-guided TB and ultrasound-guided SB. The chi-square test was used to compare the csPCa detection rates between DWI 4 and DWI 3/DCE+ lesions. Based on the TB+SB results as a standard reference, we analyzed the sensitivity, negative predictive values, and diagnostic accuracies of TB alone or SB alone. RESULTS: Patients with DWI 4 lesions had higher csPCa detection rates than those with DWI 3/DCE+ lesions when using TB+SB, TB, and SB, and the differences were significant for TB+SB or SB alone. For DWI 3/DCE+ patients whose prostate-specific antigen levels ranged from 4 to 10 ng/mL, TB alone showed the highest negative predictive value. CONCLUSIONS: Our finding suggested that DWI 4 tends to have worse results than DWI 3/DCE+. TB has an excellent ability to exclude negative csPCa in patients with DWI 3/DCE+ lesions and prostate-specific antigen levels from 4 to 10 ng/mL. Source of Funding: The Ministry of Science and Technology of China © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 207Issue Supplement 5May 2022Page: e897 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Gang Song More articles by this author Zhoujie Sun More articles by this author Expand All Advertisement PDF downloadLoading ...

MRI-based analysis of different clinically significant prostate cancer detection rate of prostate imaging reporting and data system score 4 in the peripheral zone

MP53-05 CLINICALLY SIGNIFICANT PROSTATE CANCER DETECTION RATE OF PROSTATE IMAGING REPORTING AND DATA SYSTEM SCORE 4 IN THE PERIPHERAL ZONE

Investigating the Equivalent Performance of Biparametric Compared to Multiparametric MRI in Detection of Clinically Significant Prostate Cancer

Prostate Imaging-Reporting and Data System Version 2 in Combination with Clinical Parameters for Prostate Cancer Detection: a Single Center Experience

Effectiveness and Accuracy of MRI‐Ultrasound Fusion Targeted Biopsy Based on PI‐RADS v2.1 Category in Transition/Peripheral Zone of the Prostate

[Effects of Dynamic Contrast Enhancement on Diffusion Weighted Imaging Score of 3 in Prostate Imaging Reporting and Data System Version 2 of Peripheral Zone].

Real-time precision targeted prostate biopsy using transrectal ultrasound-magnetic resonance fusion

Assessment of diagnostic value of unilateral systematic biopsy combined with targeted biopsy in detecting clinically significant prostate cancer

[Application of Dynamic Contrast Enhanced Status in Multiparametric Magnetic Resonance Imaging for Prostatic Cancer with PI-RADS 4 Lesion].

Transrectal Ultrasound Examination of Prostate Cancer Guided by Fusion Imaging of Multiparametric MRI and TRUS: Avoiding Unnecessary Mpmri-Guided Targeted Biopsy

Value of cognitive fusion targeted and standard systematic transrectal prostate biopsy for prostate cancer diagnosis

Differential diagnosis of diffuse lesion in peripheral zone of prostate by using multi-parametric MRI

Comparison of Targeted Biopsy and Combined Biopsy to Avoid Unnecessary Systematic Biopsy in Patients with PI-RADS 5 Lesions.

Magnetic Resonance Imaging-Directed Biopsy Improves The Prediction Of Prostate Cancer Aggressiveness Compared With A 12-Core Transrectal Ultrasound-Guided Prostate Biopsy

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection

Improved diagnostic accuracy of readout-segmented echo-planar imaging for peripheral zone clinically significant prostate cancer: a retrospective 3T MRI study

Diagnostic Accuracy of Targeted Magnetic Resonance Imaging and Ultrasound Fusion Biopsy and Systematic Biopsy in the Patients with Prostate Specific Antigen in Grey Area

A Clinical Available Decision Support Scheme for Optimizing Prostate Biopsy Based on Mpmri

Analysis of diagnostic efficacy of targeted biopsy versus targeted biopsy combined with systematic biopsy for patients with PI-RADS score of 4-5

[Diagnostic efficacy of prostate cancer using targeted biopsy with 6-core systematic biopsy for patients with PI-RADS 5].

Determinants of decision-making in biopsy of PI-RADS 3 transition zone lesions